Accreditation, Advocacy and Patients in MAT

AMTA Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Preconference Meeting How Can We Develop and Strengthen Patient Advocacy Groups? Day: Sunday Date: April 9, 2000 Time: 1 – 5 PM Moderator: John Finger, TexNAMA Presenters: Joycelyn Woods, NAMA Diane Fleury-Seaman, MALTA Fred Christie, AFIRM James DePasquale, Membership Director/Chapter Coordinator of NAMA…

Policy Statement Number 8 December 1, 1997 The National Alliance of Methadone Advocates supports the NIH Consensus Statement on Effective Treatment of Heroin Addiction that was facilitated by the National Institute on Drug Abuse and the National Institute of Health. The imprecate of this special statement should be understood in order to realize the impact…

PLEASE NOTE:   The inclusion of the following links does not imply the endorsement by NAMA of any information or political perspective contained therein, nor is any guarantee made about the accuracy of such material. Some of the information provided is contrary to the neuropharmacological perspective upon which methadone maintenance treatment is based. Some is…

Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…